Phase III Clinical Study on the Efficacy and Safety of Semaglutide and Ozempic® in Patients With Type 2 Diabetes
Clinical trial NCT07046273 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07046273
- Sponsor
- Shandong New Time Pharmaceutical Co., LTD
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-01
- Primary completion
- 2028-08-01
- Enrollment
- 496
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.